Middletown Life

Author: Nkarta, Inc.

Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers

April 15, 2026
Nkarta to Participate in Needham Virtual Healthcare Conference

April 9, 2026
Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights

March 25, 2026
Nkarta to Participate in March Investor Conferences

February 27, 2026